New Releases from NCBI BookshelfIsatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.
New Releases from NCBI BookshelfIsatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.